4//SEC Filing
Weiss Lawrence Martin 4
Accession 0001077183-21-000079
CIK 0001077183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:16 PM ET
Size
12.3 KB
Accession
0001077183-21-000079
Insider Transaction Report
Form 4
Weiss Lawrence Martin
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-02$53.17/sh+29,895$1,589,517→ 29,895 totalExercise: $53.17Exp: 2028-03-02→ Common Stock (29,895 underlying) - Award
Common Stock
2021-03-02+5,276→ 105,797 total
Holdings
- 27,017
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (27,017 underlying) - 6,667
Stock Option (Right to Buy)
Exercise: $9.22Exp: 2023-04-19→ Common Stock (6,667 underlying) - 8,334
Stock Option (Right to Buy)
Exercise: $13.87Exp: 2023-12-12→ Common Stock (8,334 underlying) - 37,514
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (37,514 underlying)
Footnotes (5)
- [F1]On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F2]On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2021, Dr. Weiss was granted 29,895 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001761625
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:16 PM ET
- Size
- 12.3 KB